Home › Trial NCT00022295
Phenoxodiol in Treating Patients With Refractory Solid Tumors
- Trial IDNCT00022295
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorKazia Therapeutics Limited
- Enrollment36
- Start date2001-08
- ConditionsUnspecified Adult Solid Tumor, Protocol Specific
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.